Navigation Links
Global Role of Market Research Supports Need for Training and Development Programs
Date:5/31/2013

CHAPEL HILL, N.C., May 31, 2013 /PRNewswire/ -- Training market researchers to spot and communicate key insights is a critical success factor in today's highly competitive global marketplace. As resources shrink, companies must develop market research organizations that effectively and efficiently produce high performing analysts, regardless of their location, specialty or service area.

Effective training programs can help these analytics groups create value and earn recognition from internal clients by developing analysts who can drive business results and serve as strategic partners. To help Market Research and training leaders identify strategies to ensure effective and efficient training programs, research and consulting leader Best Practices, LLC recently conducted a cross-industry research study. 

"From Classroom to Boardroom: Training can Propel Market Researchers from Order-Takers to Trusted Business Advisors" is a 82-page report that will help analytics team leaders determine if they are investing the right level of resources and developing the appropriate skill sets to create the high performing researchers they need.

According to the study, many training programs for analysts are adopting efficiency measures because of flat or shrinking budgets. Some of the measures uncovered in the study included:

  • Companies are eliminating training checklists, no longer training for the sake of training.
  • More training is individualized according to assessed needs, job requirements or interests.
  • More training is self-directed by employees and delivered on-demand via the intranet.
  • Online meetings and training sessions are replacing face-to-face events & reducing travel costs.
  • Centralizing support functions into a Center of Excellence/ Shared Services organization. 

As part of this research project, Best Practices, LLC engaged 41 Market Research and training leaders at 35 companies through a benchmarking survey instrument. In addition, research analysts conducted deep-dive executive interviews with six selected respondents to collect qualitative data and insights.

To access the full report or to download a complimentary summary containing insights found in this report, paste this link into your browser: http://www3.best-in-class.com/rr1217.htm.

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
2. NeuroDerm to Present at the Jefferies 2013 Global Healthcare Conference in New York City
3. Collegium Pharmaceuticals CEO to Present at the Jefferies 2013 Global Health Care Conference in New York on June 4, 2013
4. Lexicon To Present At The Jefferies Global Healthcare Conference
5. Array BioPharma To Present At The Jefferies 2013 Global Healthcare Conference
6. Sorrento Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference in New York City
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the Jefferies 2013 Global Healthcare Conference in New York City
8. Orexigen Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference
9. Hill-Rom to Participate in the Goldman Sachs 34th Annual Global Healthcare Conference
10. Echo Therapeutics to Present at the Jefferies Global Healthcare Conference
11. AMRI CEO to Present at the Jefferies 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Oct. 2, 2017  AllianceRx Walgreens Prime, the combined ... Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), ... which included the unveiling of new signage at its ... well as at a few other company-owned facilities across ... to patients, some of whom will begin to see ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
Breaking Medicine News(10 mins):